Article
Purple Day: Epilepsy, let's talk about it!
On the occasion of Purple Day, we met with the Neurotechnology Department at Erasmus Hospital, a key player in the fight against epilepsy. The Neurotechnology Department: a key player in the fight against epilepsy At the forefront of epilepsy management, this department stands out as an indispensable player, providing specialized expertise and advanced technologies for accurate diagnosis and continuous patient monitoring. What sets this department apart is its mobility, availability, and versatility across other services. Utilizing portable electroencephalograms, the nurses in this department intervene whenever a neurological issue in a patient needs analysis, whether it be in neurology, intensive care, neonatology, geriatrics, or elsewhere. What sets this department apart is its mobility, availability, and versatility across other services Accurate diagnosis and continuous monitoring The Neurotechnology Department has a 5-room epilepsy exploration unit, capable of accommodating patients requiring thorough diagnostic evaluations of the frequency, intensity, and origin of their symptoms for hospitalization of at least 24 hours. Sometimes even in anticipation of surgical treatment for their epilepsy. The nurses in the neurotechnology department also perform outpatient procedures: electroencephalograms and evoked potentials. With exemplary responsiveness, essential mobility, and specialized expertise, it contributes to precise diagnosis and ensures continuous monitoring of epileptic patients, resulting in improved patient care. In the fight against epilepsy, the Neurotechnology Department at Erasme Hospital emerges as a key element in patient management. Affiche de présentation du Service de Neurotechnique Le service de Neurologie Contact: nathalie [dot] buffe [at] hubruxelles [dot] be
Rich page
You are an international patient (you live abroad)
You live abroad and want to organise  hospitalisation or receive medical treatment at the H.U.B (Jules Bordet Institute, Queen Fabiola Children’s University Hospital, Erasmus Hospital)  You have social security cover in Europe For scheduled care your insurer must issue you with document S2 (formerly E112) For a medical emergency confirmed by a doctor at our institution, the EHIC (European Health Insurance Card) can be used. We ask you to check your card’s expiry date.    You do not have social security cover in Belgium or Europe Please provide the department secretariat or specialist doctor with:  Your medical file that should be as complete as possible so as to determine the treatment your health condition requires.  A copy of an official identity document and/or of your passport clearly indicating your family name, first names and date of birth.  On the basis of the information communicated by the medical team, the Preadmission Unit or Insurance Unit will provide you with an estimate of the costs of the treatment  required. If you have a payment guarantee from an insurer, please provide us with this so that the insurance Unit can validate it. If not, please make the payment of the full amount of the estimate.  Once the care has been validated, the Insurance Unit will put you into contact with the secretariat of the department or specialist doctor in charge of your file so as to plan for your arrival.  On the day of your arrival at the H.U.B please go to reception with a valid identity document (identity card or passport). 
Rich page
Symposium on Pediatric Epilepsy Surgery
On November 8, 2024, the Brussels University Hospital(H.U.B.) will host an international symposium dedicated to pediatric epilepsy neurosurgery. This event will bring together national and international experts to discuss the latest advancements and explore future perspectives in this highly specialized field Program and ThemesThe symposium will focus on several major themes aimed at improving the management of epileptic patients, particularly children resistant to medication. Topics to be covered include:Utilization of SEEG (Stereo-electroencephalography) and LITT (Laser Interstitial Thermal Therapy): These advanced techniques are crucial for pediatric patients whose epilepsy does not respond to traditional pharmaceutical treatments. SEEG provides a detailed analysis of brain activity to precisely locate epileptogenic zones, while LITT offers a minimally invasive method to treat these areas without resorting to traditional open surgery.Analysis of Neural Connectivity: This innovative method aims to predict the absence of postoperative seizures, allowing for more precise surgical planning and optimized outcomes for patients.New Surgical Approaches: The symposium will introduce a novel concept of proposing resective surgery for non-refractory focal epileptic children. The goal is to minimize the impact of antiepileptic drugs on children's cognitive development and quality of life by reducing the need for long-term pharmacological treatments.Experts and DiscussionsThe event will host renowned experts, both national and international, who will share their expertise, discuss the latest advancements, and explore future perspectives in pediatric epilepsy surgery.Registration and ProgramRegistrationProgramDate: November 8, 2024Time: 8:30 AM - 5:30 PMLocation: Musée de la Médecine, Erasme Hospital ULB, 808 route de Lennik, 1070 BrusselsContact Information: Email: Symposium_Epilepsy [dot] Neurosurgery [at] hubruxelles [dot] beFees:Medical Professionals: €60Paramedical Professionals and Students: €20
Article
Special Event at H.U.B: June 19, 2024
On June 19, 2024, Brussels University Hospital (H.U.B) invites you to a landmark event in honor of World Sickle Cell Day World Sickle Cell Day on June 19, 2024. Unveiling of the New Hospitalization Unit at Erasme. Join us as the Hematology Department at Erasme debuts its pioneering hospitalization unit designed exclusively for teenagers and adults with sickle cell disease. This milestone represents a significant leap forward in managing this intricate genetic disorder, providing a care environment meticulously tailored to meet the unique needs of its patients. Film and Testimonials Attendees will have the chance to view a documentary crafted specifically for this event, illuminating the daily challenges faced by those affected by sickle cell disease and their caregivers, alongside the latest promising therapeutic advancements. Encouraging Perspectives This event will also showcase the most recent developments in the treatment of sickle cell disease, focusing particularly on the exciting opportunities presented by gene therapy. This cutting-edge treatment modifies patients' cells to produce healthy hemoglobin. The narrative of the first patient treated with this method in Belgium will be shared. Understanding Sickle Cell Disease Sickle cell disease is a complex genetic condition that alters the properties of red blood cells and necessitates specialized, comprehensive care. The Erasme and HUDERF centers at H.U.B are renowned for their leadership in tackling this disease, providing state-of-the-art multidisciplinary care and actively driving research into innovative treatments. Registration Open Practical Information: Date and Time: June 19, 2024, beginning at 12 pm Location: Tagnon Auditorium, Jules Bordet Institute (H.U.B) Address: Rue Meylemeersch 90, 1070 Brussels The session will conclude with a networking luncheon. For further details, please contact us via email at secretariat [dot] hematologie [at] hubruxelles [dot] be (secretariat[dot]hematologie[at]hubruxelles[dot]be)
Rich page
6th Workshop of video-assisted technology in Thoracic Pathology
Organized: October 1st & 2nd 2026 at the Museum of Medicine (Erasmus Campus – Place Facultaire, Route de Lennik, 808, 1070 Brussels, Belgium). Please note: registration is free but mandatory, the event is organized on-site (no videoconferencing).  Discover the programme Find out more about the programme for the workshop, which takes place on 1 and 2 October 2026, and register using the online form. Programme Workshop of video-assisted technology in Thoracic Pathology Your personal data First name Last name Email Phone number Your profession Which institute are you working at? Your registration for the workshop : Video-assisted technology in Thoracic Pathology Jeudi 01/10/2026 - Thursday 10/01/2026 Vendredi 02/10/2026 - Friday 10/02/2026 Both days Your registration to the diner (Thursday evening -26/09/2024) Oui/Yes Non/no Please note: this is a paid dinner event. If you selected “Yes”, a fee of 50 euros will be charged. They support us This workshop is supported by:Belgian Respiratory Society (BeRS)Royal Belgian Society for Surgery (RBSS)Belgian Section of Thoracic Surgery (BeSTS) Our sponsors Contact Mélissa BourleauEmail : Melissa [dot] Bourleau [at] hubruxelles [dot] be (Melissa[dot]Bourleau[at]hubruxelles[dot]be)Phone number : +32 (0)2 555 53 49
Article
World Eating Disorders Action Day: Detecting and Treating Eating Disorders in Youth
In the complex landscape of youth mental health, eating disorders (EDs) present significant challenges, requiring sustained attention and swift action. As June 2nd marks World Eating Disorders Action Day, raising awareness about the early detection and treatment of these devastating disorders is crucial What Are Eating Disorders? Eating disorders involve much more than just disturbed eating habits. They are psychiatric illnesses characterized by a dysfunctional relationship with food, weight, and body image. Predominantly observed in adolescents, these disorders can appear at any age and affect men as well. Anorexia nervosa, bulimia nervosa, and binge eating disorder are among the most common forms, with profound impacts on an individual's physical and mental health.Early DetectionThe vigilance of parents and healthcare professionals is essential in identifying the early signs of EDs. Any changes in eating habits, an obsession with weight and appearance, and signs of social withdrawal and low self-esteem must be taken seriously. Early detection can prevent severe complications and improve the chances of recovery.Family-Based Therapy (FBT)For those who suspect the presence of an ED in their child or adolescent, prompt medical consultation is imperative. At Erasme Hospital and the Children's Hospital, Silvana Fuso, a specialist in EDs, offers an innovative approach with Family-Based Therapy (FBT). This method actively involves parents in the therapeutic process, providing crucial familial support for recovery.Read our page dedicated to this health issueContact InformationTo schedule an appointment with Silvana Fuso:Erasme Hospital: EMC Child and Adolescent ConsultationSecretariat: +32 2 555 32 96Appointment Request FormChildren's Hospital (Huderf)University Children's Hospital's Child Psychiatry Service: +32 2 477 3180Appointment Request Form
Rich page
Healthcare professionals
Lien vers Doctors General practitioners and specialists Doctors Image Lien vers Nurses Paramedical sector Nurses Image
Article
Epilepsy neurosurgery: honoring a rare specialty
In November 2024, this specialty will be highlighted during a dedicated event, underscoring the importance and advancements of epilepsy neurosurgery in Belgium. Healthcare professionals will have the opportunity to gather, share their knowledge, and explore new perspectives offered by this discipline. Epilepsy neurosurgery in Belgium: a leading specializationIn Belgium, neurosurgery, and more specifically epilepsy neurosurgery, represents a medical specialty that is both advanced and rare. Essential for the treatment of patients with epilepsy who are refractory to traditional medication treatments, this discipline is distinguished by its cutting-edge techniques and promising results.State-of-the-art equipment at the H.U.B.The Brussel University Hospital (H.U.B.) stands out for its use of advanced technologies for the treatment of epilepsy, notably SEEG (stereo-electroencephalography) and, soon, LITT (laser interstitial thermotherapy). The H.U.B. boasts some of the leading specialists who utilize this advanced equipment, crucial for pediatric patients resistant to traditional pharmaceutical treatments.SEEG: precision and effectivenessSEEG provides a detailed mapping of brain activity, accurately pinpointing epileptogenic zones. With this technique, neurosurgeons can identify the areas responsible for epileptic seizures with great precision, facilitating more targeted and effective interventions.LITT: minimally invasive innovationSoon, the H.U.B. will integrate LITT into its treatment protocols. This technique offers a minimally invasive solution for treating the epileptogenic zones identified by SEEG, using a laser to destroy the brain tissue responsible for seizures. LITT serves as an effective alternative to traditional open surgeries when the functional or cognitive risk is too high. It provides a curative solution for patients who were previously deemed inoperable.An international symposium in November 2024On November 8, 2024, the H.U.B. will host an international symposium dedicated to epilepsy neurosurgery. This event will bring together world-renowned experts to discuss the latest advancements and innovative perspectives in this highly specialized field. The goal is to improve the care of epilepsy patients and to promote cutting-edge surgical techniques.Practical InformationDate: November 8, 2024Time: 8:30 AM - 5:30 PMLocation: Museum of Medicine, Erasme Hospital ULB, 808 route de Lennik, 1070 BrusselsTo access the detailed program and register, please follow this link.
Article
25 years of the Gamma Knife Centre at the H.U.B
On 25 October 2024 Brussels University Hospital will be celebrating 25 years of its Gamma Knife Centre. Image To mark the occasion, a scientific day in the presence of experts is being organised. Practical informationWhen? 25 October 2024 from 9 am to 5:30 pmWhere? The Royal Library of Belgium –Boulevard de l’Empereur,4 -1000 Brussels Program Click here Accreditation in ethics and economicsRegistration REGISTRATION
Rich page
Payment plan request form
Title First name Last name National Security number File number Invoice number Phone number / mobile Email Number of monthly instalments / Amount Your motivation
Rich page
SICKEL CELL DISEASE AWARNESS DAY
JUNE 19, 2024 | 12:00 PM - 2:00 PM H.U.B is proud to support the SICKEL CELL DISEASE AWARNESS DAY On this occasion, we are pleased to present: The first unit for adolescent and adult hospitalization Videos and testimonials An overview of the latest innovations for this rare disease Join us on June 19 at 12:00 PM at Auditorium Tagnon The presentation will be followed by a luncheon cocktail Registration Open Date and Time: June 19, 2024, beginning at 12 pm Location: Tagnon Auditorium, Jules Bordet Institute (H.U.B) Address: Rue Meylemeersch 90, 1070 Brussels The session will conclude with a networking luncheon. For further details, please contact us via email at secretariat [dot] hematologie [at] hubruxelles [dot] be (secretariat[dot]hematologie[at]hubruxelles[dot]be)
Rich page
Clinic for Inflammatory Bowel Diseases (IBD)
Image Contact the Inflammatory Bowel Disease (IBD) Clinic. Would you like to make an appointment for a consultation with an IBD clinic specialist for yourself or for one of your relatives?Contact us by phone at +32 (0)2 555 35 04 or by email at: ibd [dot] erasme [at] hubruxelles [dot] beWould you like to make an appointment for an endoscopy with an IBD clinic specialist for yourself or for one of your relatives?Contact us by phone at +32 (0)2 555 3292 or by email at: ibd [dot] erasme [at] hubruxelles [dot] beAre you a patient and do you have an administrative request (prescriptions, reimbursements, certificates, insurance documents, or copies of medical records)?Contact our medical administration by phone at +32 (0)2 555 5422 or by email at: ibd [dot] erasme [at] hubruxelles [dot] beAre you a doctor and would you like to obtain medical results for your patients, refer a patient, or request a (second) opinion?Contact our clinic by phone at +32 (0)2 555 54 22 or by email at: ibd [dot] erasme [at] hubruxelles [dot] be Do you suffer from an Inflammatory Bowel Disease (IBD)? The Inflammatory Bowel Diseases (IBD) Clinic provides care for all patients with Crohn’s disease, ulcerative colitis, unclassified colitis, lymphocytic/collagenous colitis, as well as celiac disease and intestinal autoimmune diseases or vasculitis Image Image Image Comprehensive care Several specialized consultations are developed for the management of adolescents, pregnant or breastfeeding women, screening for primary immunodeficiency syndromes in adults, and patients with celiac disease or autoimmune enteritis. Multidisciplinary approach There is strong multidisciplinary collaboration in the care of patients with inflammatory bowel disease, particularly during a weekly meeting (“round table”) with colorectal surgeons, radiologists, pathologists, rheumatologists, and dermatologists (as well as ophthalmologists or other specialists involved in immunodeficiency-related conditions).  Discover the Inflammatory Bowel Disease (IBD) Clinic of Hôpital Erasme H.U.B. Image Prof. Denis Franchimont, Director of the Inflammatory Bowel Diseases Clinic SpecialtiesInflammatory bowel diseases.Colon cancer screening and genetic screening for hereditary colorectal cancer syndromes.Diagnostic and therapeutic gastroscopy and colonoscopy.Upper digestive and anorectal endoscopic ultrasound.Resection of superficial colorectal tumors.  Prendre rendez-vous avec le Prof. Franchimont A team of specialists by your side DoctorsProf. Claire LiefferinckxProf. Anneline CremerProf. Leila AmininejadDr. Cagla GulkilikDr. Clémence VukovicProf. Denis FranchimontClinical studies and trials coordinationCharlotte Minsart, PhD in Biomedical SciencesEmma DescampsChloé HelmanClinic coordinating nurseValérie WambacqDietitianPauline Van OuytselConsultantsDr. Vincent BouillonDr. Haydeh Vafa ZanjaniMedical secretaryGeorgiana Vilcinschi A clinic committed to research The clinic is actively involved in pharmaceutical clinical research (we have access to new molecules within international clinical trials), as well as translational and genetic research, particularly in collaboration with the BIRD (Belgium IBD Research Disease Group), the ECCO (European Crohn’s and Colitis Organisation), and the IIBDGC (International IBD Genetics Consortium)BIRD (Belgium IBD Research Disease Group), l’ECCO (European Crohn and Colitis Organisation) et le IIBDGC (International IBD Genetics Consortium).  In 2022, the clinic opened its translational research laboratory on the microbiota — the H.U.B Center for the Study of Inflammatory Bowel Disease (IBD) and Microbiota — where 3 physicians, a technician, two PhD students, and an artificial intelligence engineer work Our scientific publications In-depth study of monogenic primary immunodeficiency genes identifies rare XIAP variants in Crohn’s disease patients. Amininejad L, Charloteaux B, Theatre E, Dmitrieva J, Hayard P, Muls V, Maisin J-M, Schapira M, Ghislain J-M, Closset P, Talib M, Abramowicz M, Momozawa Y, Deffontaine V, Crins F, Mni M, Karim L, Cambisano N, Deviere J, Hugot J-P, De vos M, Louis E, Vermeire S, Van Gossum A, Coppieters W, Twizere J-C, Georges M, Franchimont D.  Gastroenterology 2018 Jun;154(8):2165-2177 (I.F. 33) 01 June 2018 Lien vers https://pubmed.ncbi.nlm.nih.gov/31202983/ Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia Cremer A, Demetter P, De Vos M, Rahier JF, Baert F, Moreels T, Macken E, Louis E, Ferdinande L, Fervaille C, Dedeurwaerdere F, Bletard N, Driessen A, De Hertogh G, Vermeire S, Franchimont D.  Clin Gastroenterol Hepatol. 2019 Jun 13. pii: S1542-3565(19)30645-7 13 June 2019 Lien vers https://www.researchgate.net/publication/350498118_Collecting_New_Peak_and_Inte… Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases Liefferinckx C, Bottieau J, Toubeau JF, Thomas D, Rahier JF, Louis E, Baert F, Dewint P, Pouillon L, Lambrecht G, Vallée F, Vermeire S, Bossuyt P, Franchimont D.  Inflamm Bowel Dis. 2022 Feb 1;28(2):208-217.  01 February 2022 Lien vers https://www.nature.com/articles/s41588-022-01156-2 Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease susceptibility . Sazonovs A, Stevens CR, Venkataraman GR, Yuan K, Avila B, Abreu MT, Ahmad T, Allez M, Ananthakrishnan AN, Atzmon G, Baras A, Barrett JC, Barzilai N, Beaugerie L, Beecham A, Bernstein CN, Bitton A, Bokemeyer B, Chan A, Chung D, Cleynen I, Cosnes J, Cutler DJ, Daly A, Damas OM, Datta LW, Dawany N, Devoto M, Dodge S, Ellinghaus E, Fachal L, Farkkila M, Faubion W, Ferreira M, Franchimont D, Gabriel SB, Ge T, Georges M, Gettler K, Giri M, Glaser B, Goerg S, Goyette P, Graham D, Hämäläinen E, Haritunians T, Heap GA, Hiltunen M, Hoeppner M, Horowitz JE, Irving P, Iyer V, Jalas C, Kelsen J, Khalili H, Kirschner BS, Kontula K, Koskela JT, Kugathasan S, Kupcinskas J, Lamb CA, Laudes M, Lévesque C, Levine AP, Lewis JD, Liefferinckx C, Loescher BS, Louis E, Mansfield J, May S, McCauley JL, Mengesha E, Mni M, Moayyedi P, Moran CJ, Newberry RD, O'Charoen S, Okou DT, Oldenburg B, Ostrer H, Palotie A, Paquette J, Pekow J, Peter I, Pierik MJ, Ponsioen CY, Pontikos N, Prescott N, Pulver AE, Rahmouni S, Rice DL, Saavalainen P, Sands B, Sartor RB, Schiff ER, Schreiber S, Schumm LP, Segal AW, Seksik P, Shawky R, Sheikh SZ, Silverberg MS, Simmons A, Skeiceviciene J, Sokol H, Solomonson M, Somineni H, Sun D, Targan S, Turner D, Uhlig HH, van der Meulen AE, Vermeire S, Verstockt S, Voskuil MD, Winter HS, Young J; Belgium IBD Consortium; Cedars- Sinai IBD; International IBD Genetics Consortium; NIDDK IBD Genetics Consortium; NIHR IBD BioResource; Regeneron Genetics Center; SHARE Consortium; SPARC IBD Network; UK IBD Genetics Consortium; Duerr RH, Franke A, Brant SR, Cho J, Weersma RK, Parkes M, Xavier RJ, Rivas MA, Rioux JD, McGovern DPB, Huang H, Anderson CA, Daly MJ.  Nat Genet. 2022 Sep;54(9):1275-1283.  29 August 2022 Resources and Useful Links for Patients with Crohn’s Disease, Colitis, and Inflammatory Bowel Diseases (IBD) Whether you have already been diagnosed or suspect you may have an inflammatory bowel disease (IBD), we are here to support and guide you step by step. That is why we offer a series of content (produced by doctors, researchers, patient associations, and public health stakeholders) to help you better understand your disease, manage it, and identify support groups with which to connect. ASSOCIATION - L’association Crohn-RCUH asbl tente de répondre aux besoins socia… ASSOCIATION - Société Belgique de la Coeliaquie PODCAST - MICI Today Le podcast dédié aux affections inflammatoires du tube dig… FONDATION - BRIDGE - Brussels IBD Effort, a Network of ULB Hospitals FAQ on Crohn's disease and Colites 1. What is Crohn’s disease? Crohn’s disease is a chronic inflammatory bowel disease (IBD) that can affect any part of the digestive tract, from the mouth to the anus. It is characterized by segmental inflammation and can lead to complications such as strictures or fistulas. 2. 2. What are the differences between Crohn’s disease and other types of colitis? Crohn’s disease can affect the entire digestive tract, with discontinuous lesions.Ulcerative colitis (UC) affects only the colon and rectum, with continuous lesions.Infectious colitis is caused by bacteria, viruses, or parasites and is usually temporary.Ischemic colitis results from reduced blood flow to the colon.Microscopic colitis (lymphocytic and collagenous) is only visible under a microscope and causes chronic diarrhea. 3. What are the main symptoms of Crohn’s disease? Symptoms include abdominal pain, diarrhea (sometimes with blood), weight loss, fatigue, and sometimes fever. Extra-intestinal manifestations may also occur, such as joint pain, skin rashes, or eye problems. 4. Is Crohn’s disease hereditary? There is a genetic predisposition: about 10 to 20% of patients have a family member with an inflammatory bowel disease (IBD). However, environmental and immunological factors are also required for the disease to develop.  5. How is Crohn’s disease distinguished from infectious colitis? Infectious colitis is usually acute and caused by an identifiable infection (bacteria, viruses, parasites). Stool tests can confirm the infectious origin. Crohn’s disease, on the other hand, is chronic, with recurrent flare-ups and periods of remission. 6. What treatments are available for Crohn’s disease? Treatments include:Anti-inflammatory drugs (such as mesalazine or corticosteroids).Immunosuppressants (azathioprine, methotrexate).Biologic therapies targeting specific molecules (anti-TNF, anti-IL12/23, etc.).In case of complications, surgery may be required to remove affected segments of the intestine. 7. Can Crohn’s disease cause serious complications? Yes, it can lead to:Stenoses (narrowing of the intestine that may cause obstructions).Fistulas (abnormal connections between organs or with the skin).Abscesses.Increased risk of colorectal cancer (in cases of long-term inflammation). 8. Which factors worsen colitis and Crohn’s disease? Stress and anxiety can worsen symptoms.Smoking particularly aggravates Crohn’s disease.An unbalanced or irritating diet can intensify flare-ups. 9. Can diet prevent or cure colitis and Crohn’s disease? There is no diet that can cure the disease, but certain dietary choices may help relieve symptoms. Low-residue or low-FODMAP diets are often used during flare-ups. A balanced diet is essential to avoid deficiencies. 10. How do people live with a chronic disease like Crohn’s disease or colitis? With appropriate treatment, many patients can achieve remission and lead a normal life.Regular follow-up with a gastroenterologist is important.Participation in support groups or patient associations can help cope with the psychological impact of the disease. Supported by